Fish on the Quay in Maldon closed by council over rat infestation
A seafood restaurant has been shut down after a widespread rat infestation was found at its premises.Fish on the Quay was visited by hygiene officers from Maldon District Council, who took court action on Thursday.Council leader Richard Siddall said "incredibly serious offences" had been identified at the venue in the Essex town.When contacted by the BBC, a manager vowed to reopen on Friday and insisted "everything is great".
The restaurant in Hythe Quay - which is also home to a pub and a bed and breakfast - is "committed to sourcing the freshest ingredients", according to its website.A Hygiene Emergency Prohibition Order, made at Chelmsford Magistrates' Court, meant health risks must be removed before reopening.
Council officers have been working with the business, which also offers a bed and breakfast service, to protect visitors, staff and nearby residents.Siddall, a Maldon District Independent, said there had been an "imminent risk to public health".He stressed having an "active and widespread" rat infestation could have had "terrible consequences" for customers."Whilst these are incredibly serious offences, we will work with the operator to improve the standards of cleanliness and make sure that they comply with food safety standards before they reopen," the council leader added.
Follow Essex news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
17 minutes ago
- The Independent
Nearly 600 heat-related deaths expected in UK heatwave, researchers estimate
Nearly 600 people in England and Wales are predicted to die as a result of this week's heatwave, researchers have found. Experts at the London School of Hygiene and Tropical Medicine (LSHTM) and Imperial College London used decades of UK data to predict excess mortality during the hot temperatures from Thursday to Sunday. Their study, released on Saturday, forecasts that around 570 people will die because of the heat over the four days. The excess deaths are estimated to peak at 266 on Saturday when the heat will be at its most intense. London is predicted to have the greatest number of excess deaths with 129. The researchers said their assessment highlights how extreme heat poses a growing threat to public health in the UK. It follows a World Weather Attribution (WWA) research group study published on Friday which found the heatwave has been made about 100 times more likely and 2-4C hotter due to climate change. Dr Garyfallos Konstantinoudis, lecturer at the Grantham Institute at Imperial College London, said: 'Heatwaves are silent killers – people who lose their lives in them typically have pre-existing health conditions and rarely have heat listed as a contributing cause of death. 'This real-time analysis reveals the hidden toll of heatwaves and we want it to help raise the alarm. 'Heatwaves are an underappreciated threat in the UK and they're becoming more dangerous with climate change.' Dr Konstantinoudis warned that people should follow heat-health advice this weekend and check on older people, particularly those living alone. Temperatures had been forecast to hit 32C across the South East on Saturday and had already reached that level on Thursday in London. The UK Health Security Agency issued an amber heat-health alert covering all of England to warn vulnerable populations of the health risks, including 'a rise in deaths'. Dozens of people required treatment for heat-related illness at Royal Ascot on Thursday. The researchers used findings from published research on the relationship between heat and the number of daily deaths, regardless of the cause, in 34,753 areas of England and Wales. They combined these with high-resolution weather forecasts from the Copernicus climate change service to estimate how many heat-related deaths will occur. They estimated that 114 excess deaths would have occurred on Thursday, 152 on Friday, 266 on Saturday and 37 deaths on Sunday, when temperatures will fall to the mid-20s. People above 65 are expected to be hardest hit, with 488 of the estimated excess deaths, the report said. But the experts also warn that heat can be life-threatening for all ages, with 82 deaths estimated for people aged under 65. They also note that the analysis does not account for the effect of the heatwave occurring early in summer before people are acclimatised to hot temperatures, meaning deaths could be underestimated. A recent report by the UK Climate Change Committee estimated that heat-related deaths could rise to more than 10,000 in an average year by 2050 if fossil fuel burning causes warming to reach 2C. UN scientists warned this week that the world is in 'crunch time' to limit warming and has three years left to prevent global average temperature rises exceeding 1.5C. Professor Antonio Gasparrini, of the LSHTM, said: 'Increases of just a degree or two can be the difference between life and death. 'Every fraction of a degree of warming will cause more hospital admissions and heat deaths, putting more strain on the NHS.' Dr Malcolm Mistry, assistant professor at the LSHTM, said: 'Exposure to temperatures in the high 20s or low 30s may not seem dangerous, but they can be fatal, particularly for people aged over 65, infants, pregnant people and those with pre-existing health conditions. 'Unless effective mitigation and adaptive measures are put in place in the coming years, the risk of large heat-related death events is set to increase in the UK – we have a large ageing population and warming is expected to increase to 2C by 2050 and as high as 3C this century.' Dr Lorna Powell, an NHS urgent care doctor in east London who was not involved in the study, said: 'We are seeing cases of heat-related illnesses rising in our urgent care departments. 'Heat exhaustion can quickly trigger more serious illnesses as dehydration sets in and the cardiovascular system becomes overwhelmed.'
Daily Mail
21 minutes ago
- Daily Mail
Every newborn baby in the UK will have DNA screening in NHS 'revolution' to battle killer diseases, Wes Streeting reveals
Every newborn baby in the UK will have a DNA screening as part of an NHS 'revolution' to battle killer diseases. The health secretary Wes Streeting said new technology in areas such as genomics would help 'leapfrog' illnesses. The Government is set to pour £650 million into DNA technology in an effort to treat serious illnesses before they become a problem. The investment in genomics is expected to support the Government's 10-year plan for the NHS, which will see a greater focus on technology and prevention. Mr Streeting told The Telegraph: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it. 'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.' Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. He added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.' Along with a greater focus on prevention, the Government's 10-year plan is expected to include Mr Streeting's two other 'shifts' in the NHS. That will see a shift away from hospitals towards more community-focused care, and from analogue to digital services. It follows Chancellor Rachel Reeves' announcement that the Government would increase NHS funding by £29 billion per year in real terms over the next three years as it tries to cut waiting lists in line with its election promises.
The Independent
29 minutes ago
- The Independent
Weight loss jab could be used to treat migraines
Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. Researchers have discovered, GLP-1 drug liraglutide, commonly used to treat diabetes, has the potential to significantly reduce migraine frequency. Migraines affect approximately 6 million people in the UK, according to the NHS. Attacks can last for three days causing pain, nausea, vomiting, dizziness and sensitivity to light, sound and smells. Researchers at the Headache Centre of the University of Naples gave 26 adults with obesity and chronic migraines the drug liraglutide. The study presented at the European Academy of Neurology (EAN) Congress 2025, found those who had the drug reported an average of 11 fewer headache days per month. Participants also experienced meaningful improvements in quality of life, work, study, and social functioning within just two weeks of taking the drug. 'Most patients felt better within the first two weeks and reported quality of life improved significantly', said lead researcher Dr Simone Braca. 'The benefit lasted for the full three-month observation period, even though weight loss was modest and statistically non-significant.' Growing evidence has linked subtle increases in intracranial pressure to migraine attacks. It's caused by a rise in the pressure of cerebrospinal fluid – which surrounds the brain and spinal cord. This increase in pressure can happen because of a severe head injury, stroke, a brain tumour or high blood pressure. But GLP-1-receptor agonists such as liraglutide reduce cerebrospinal fluid secretion and have already proved effective in treating idiopathic intracranial hypertension (IIH). Patients in the study were screened to exclude papilledema (optic disc swelling resulting from increased intracranial pressure) and sixth nerve palsy, ruling out IIH. Dr Braca and colleagues believe GLP-1 drugs may reduce the release of CGRP (calcitonin gene-related peptide), a key molecule behind migraines. 'We think that, by modulating cerebrospinal fluid pressure and reducing intracranial venous sinuses compression, these drugs produce a decrease in the release of calcitonin gene-related peptide (CGRP), a key migraine-promoting peptide', Dr Braca said. 'That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway.' Given liraglutide's established use in type 2 diabetes and obesity, it may represent a promising case of drug repurposing in neurology, study authors said.
